MétaCan
Menu
Back to cohort
Record W2587748078 · doi:10.1093/ecco-jcc/jjx002.791

P667 Safety of anti-TNF treatment in liver transplant recipients – a meta-analysis

2017· article· en· W2587748078 on OpenAlexaboutno aff
Menso Westerouen van Meeteren, Akin Inderson, Bu Hayee, Romain Altwegg, Bart van Hoek, G.-P. Pageaux, T. Stijnen, Dan J. Stein, Jeroen Maljaars

Bibliographic record

VenueJournal of Crohn s and Colitis · 2017
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineInternal medicineLiver transplantationImmunosuppressionCohortPopulationCohort studyPrimary sclerosing cholangitisTransplantationDisease

Abstract

fetched live from OpenAlex

Background: Primary Sclerosing Cholangitis (PSC) patients with refractory inflammatory bowel disease (IBD) after liver transplantation (LT) pose a dilemma for treating physicians, as little is known about the risk of serious infection when combining anti-TNF therapy with immunosuppression for prevention of rejection. Our aim was to investigate the infection risk in this patient group by systematic review and meta-analysis of the available data. Methods: A literature search was conducted for full papers and conference proceedings through September 2015 regarding liver transplant recipients and anti-TNF therapy. All studies were appraised using the adapted Newcastle-Ottawa Scale (NOS), which contains 9 criteria for cohort studies and is adapted to 6 criteria for case series and case reports. Two reviewers (MWvM and PWJM) independently extracted study and control-patient data (age, duration of follow up, number of all infections, number of serious infections, time since transplant). As additional control population, PSC-IBD patients from the LUMC LT cohort were used. Poisson regression was used to compare serious infections (according to ICH-definition) per patient year follow up between the anti-TNF and control group, correcting for mean time since transplant. Results: Initially, 465 articles and abstracts were identified, of which 8 were included. These 8 studies contained 53 post-LT patients on anti-TNF therapy and 23 post-LT control patients not on anti-TNF therapy. None of the studies scored less than 75% of the NOS quality criteria. From the LUMC LT cohort, 41 PSC-patients with PSC-IBD but without anti-TNF therapy were included as control population. Serious infection rates differed from 0 to 0.38 serious infections per patient year in the anti-TNF therapy group, and 0.04 to 0.24 in the control group. The overall infection rate for TNF-exposed patients was 0.12, compared to 0.15 in the control patients, resulting in a rate ratio of 0.80 (95% CI: 0.17–3.97, p=0.80). Age at time of transplant was not associated with the rate ratio for serious infections, whereas the time since transplantation was. Although correcting for time since transplant causes the infection rates in the anti-TNF-group to be higher than in the control group (0.13 vs 0.12 serious infections per patient year) the rate ratio remained non-significant (1.1, p=0.82). Conclusions: No significant increase in the serious infection rate was observed in LT-recipients with PSC-IBD during exposure to anti-TNF therapy. However, the wide confidence intervals of these results show that more data is needed to provide a definitive conclusion on the safety of anti-TNF therapy in these patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.025
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.015
Threshold uncertainty score0.082

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.025
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0120.047
Bibliometrics0.0040.005
Science and technology studies0.0010.001
Scholarly communication0.0030.001
Open science0.0020.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.055
GPT teacher head0.308
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicLiver Diseases and ImmunityFrench-language works237,207